David T Feinberg insider trades
Open-market stock purchases and sales by David T Feinberg, Director at Edwards Lifesciences Corp, from SEC Form 4 filings since Aug 11, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -40%.